Literature DB >> 24899188

Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.

Yukiko Muramoto1, Jason E Shoemaker2, Mai Quynh Le3, Yasushi Itoh4, Daisuke Tamura1, Yuko Sakai-Tagawa1, Hirotaka Imai1, Ryuta Uraki1, Ryo Takano1, Eiryo Kawakami2, Mutsumi Ito1, Kiyoko Okamoto4, Hirohito Ishigaki4, Hitomi Mimuro5, Chihiro Sasakawa6, Yukiko Matsuoka2, Takeshi Noda1, Satoshi Fukuyama2, Kazumasa Ogasawara4, Hiroaki Kitano7, Yoshihiro Kawaoka8.   

Abstract

UNLABELLED: Occasional transmission of highly pathogenic avian H5N1 influenza viruses to humans causes severe pneumonia with high mortality. To better understand the mechanisms via which H5N1 viruses induce severe disease in humans, we infected cynomolgus macaques with six different H5N1 strains isolated from human patients and compared their pathogenicity and the global host responses to the virus infection. Although all H5N1 viruses replicated in the respiratory tract, there was substantial heterogeneity in their replicative ability and in the disease severity induced, which ranged from asymptomatic to fatal. A comparison of global gene expression between severe and mild disease cases indicated that interferon-induced upregulation of genes related to innate immunity, apoptosis, and antigen processing/presentation in the early phase of infection was limited in severe disease cases, although interferon expression was upregulated in both severe and mild cases. Furthermore, coexpression analysis of microarray data, which reveals the dynamics of host responses during the infection, demonstrated that the limited expression of these genes early in infection led to a failure to suppress virus replication and to the hyperinduction of genes related to immunity, inflammation, coagulation, and homeostasis in the late phase of infection, resulting in a more severe disease. Our data suggest that the attenuated interferon-induced activation of innate immunity, apoptosis, and antigen presentation in the early phase of H5N1 virus infection leads to subsequent severe disease outcome. IMPORTANCE: Highly pathogenic avian H5N1 influenza viruses sometimes transmit to humans and cause severe pneumonia with ca. 60% lethality. The continued circulation of these viruses poses a pandemic threat; however, their pathogenesis in mammals is not fully understood. We, therefore, investigated the pathogenicity of six H5N1 viruses and compared the host responses of cynomolgus macaques to the virus infection. We identified differences in the viral replicative ability of and in disease severity caused by these H5N1 viruses. A comparison of global host responses between severe and mild disease cases identified the limited upregulation of interferon-stimulated genes early in infection in severe cases. The dynamics of the host responses indicated that the limited response early in infection failed to suppress virus replication and led to hyperinduction of pathological condition-related genes late in infection. These findings provide insight into the pathogenesis of H5N1 viruses in mammals.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24899188      PMCID: PMC4136255          DOI: 10.1128/JVI.00907-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  99 in total

1.  Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome.

Authors:  Kadir Turan; Masaki Mibayashi; Kenji Sugiyama; Shoko Saito; Akiko Numajiri; Kyosuke Nagata
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

Review 2.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

3.  Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin.

Authors:  Rie Watanabe; George P Leser; Robert A Lamb
Journal:  Virology       Date:  2011-05-28       Impact factor: 3.616

4.  Seroevidence for H5N1 influenza infections in humans: meta-analysis.

Authors:  Taia T Wang; Michael K Parides; Peter Palese
Journal:  Science       Date:  2012-02-23       Impact factor: 47.728

Review 5.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

6.  Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia.

Authors:  Kazuko Yamamoto; Joseph D Ferrari; Yuxia Cao; Maria I Ramirez; Matthew R Jones; Lee J Quinton; Joseph P Mizgerd
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

7.  Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis).

Authors:  T Kuiken; G F Rimmelzwaan; G Van Amerongen; A D M E Osterhaus
Journal:  Vet Pathol       Date:  2003-05       Impact factor: 2.221

8.  Experimental infection of non-human primates with avian influenza virus (H9N2).

Authors:  Kun Zhang; Weiwei Xu; Zhaowei Zhang; Tiecheng Wang; Xiaoyu Sang; Kaihui Cheng; Zhijun Yu; Xuexing Zheng; Huale Wang; Yongkun Zhao; Geng Huang; Songtao Yang; Chuan Qin; Yuwei Gao; Xianzhu Xia
Journal:  Arch Virol       Date:  2013-05-12       Impact factor: 2.574

9.  Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection.

Authors:  Caroline Lai; Jessica J Struckhoff; Jana Schneider; Luis Martinez-Sobrido; Thorsten Wolff; Adolfo García-Sastre; Dong-Er Zhang; Deborah J Lenschow
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

10.  Re-emergence of fatal human influenza A subtype H5N1 disease.

Authors:  J S M Peiris; W C Yu; C W Leung; C Y Cheung; W F Ng; J M Nicholls; T K Ng; K H Chan; S T Lai; W L Lim; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

View more
  21 in total

1.  The Influenza A Virus Genotype Determines the Antiviral Function of NF-κB.

Authors:  Sharmistha Dam; Michael Kracht; Stephan Pleschka; M Lienhard Schmitz
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

2.  AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells.

Authors:  Leigh M Howard; Johannes B Goll; Travis L Jensen; Kristen L Hoek; Nripesh Prasad; Casey E Gelber; Shawn E Levy; Sebastian Joyce; Andrew J Link; C Buddy Creech; Kathryn M Edwards
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

3.  Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.

Authors:  Elizabeth R Wonderlich; Zachary D Swan; Stephanie J Bissel; Amy L Hartman; Jonathan P Carney; Katherine J O'Malley; Adebimpe O Obadan; Jefferson Santos; Reagan Walker; Timothy J Sturgeon; Lonnie J Frye; Pauline Maiello; Charles A Scanga; Jennifer D Bowling; Anthea L Bouwer; Parichat A Duangkhae; Clayton A Wiley; JoAnne L Flynn; Jieru Wang; Kelly S Cole; Daniel R Perez; Douglas S Reed; Simon M Barratt-Boyes
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

Review 4.  The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.

Authors:  A Sally Davis; Jeffery K Taubenberger; Mike Bray
Journal:  Antiviral Res       Date:  2015-03-05       Impact factor: 5.970

5.  Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.

Authors:  Yasushi Itoh; Shintaro Shichinohe; Misako Nakayama; Manabu Igarashi; Akihiro Ishii; Hirohito Ishigaki; Hideaki Ishida; Naoko Kitagawa; Takako Sasamura; Masanori Shiohara; Michiko Doi; Hideaki Tsuchiya; Shinichiro Nakamura; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida; Kazumasa Ogasawara
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

6.  Pathogenesis of Influenza A(H7N9) Virus in Aged Nonhuman Primates.

Authors:  Satoshi Fukuyama; Kiyoko Iwatsuki-Horimoto; Maki Kiso; Noriko Nakajima; Robert W Gregg; Hiroaki Katsura; Yuriko Tomita; Tadashi Maemura; Tiago Jose da Silva Lopes; Tokiko Watanabe; Jason E Shoemaker; Hideki Hasegawa; Seiya Yamayoshi; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

7.  A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets.

Authors:  Masaki Imai; Tokiko Watanabe; Maki Kiso; Noriko Nakajima; Seiya Yamayoshi; Kiyoko Iwatsuki-Horimoto; Masato Hatta; Shinya Yamada; Mutsumi Ito; Yuko Sakai-Tagawa; Masayuki Shirakura; Emi Takashita; Seiichiro Fujisaki; Ryan McBride; Andrew J Thompson; Kenta Takahashi; Tadashi Maemura; Hiromichi Mitake; Shiho Chiba; Gongxun Zhong; Shufang Fan; Kohei Oishi; Atsuhiro Yasuhara; Kosuke Takada; Tomomi Nakao; Satoshi Fukuyama; Makoto Yamashita; Tiago J S Lopes; Gabriele Neumann; Takato Odagiri; Shinji Watanabe; Yuelong Shu; James C Paulson; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  Cell Host Microbe       Date:  2017-10-19       Impact factor: 21.023

8.  ETV7 limits antiviral gene expression and control of influenza viruses.

Authors:  Heather M Froggatt; Alfred T Harding; Ryan R Chaparian; Nicholas S Heaton
Journal:  Sci Signal       Date:  2021-07-13       Impact factor: 8.192

9.  The contribution of PA-X to the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian influenza viruses.

Authors:  Huijie Gao; Yipeng Sun; Jiao Hu; Lu Qi; Jinliang Wang; Xin Xiong; Yu Wang; Qiming He; Yang Lin; Weili Kong; Lai-Giea Seng; Honglei Sun; Juan Pu; Kin-Chow Chang; Xiufan Liu; Jinhua Liu
Journal:  Sci Rep       Date:  2015-02-05       Impact factor: 4.379

Review 10.  Systems biology: A tool for charting the antiviral landscape.

Authors:  James R Bowen; Martin T Ferris; Mehul S Suthar
Journal:  Virus Res       Date:  2016-01-12       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.